Recommended Topic Related To:

Levaquin

"Jan. 24, 2013 -- The flu is not the only highly contagious disease raging this winter.

A new strain of norovirus is causing intestinal illness outbreaks across the country, the CDC confirmed today.

Norovirus is often to blame when "...

Levaquin

Levaquin Side Effects Center

Pharmacy Editor: Omudhome Ogbru, PharmD

Levaquin (levofloxacin) is an antibiotic for treating several types of bacterial infections. A generic formulation is available. Common side effects of Levaquin include nausea or vomiting, diarrhea, headache, and constipation. Difficulty sleeping, dizziness, abdominal pain, rash, abdominal gas, and itching also occur. Levaquin has been associated with tendinitis and even rupture of tendons. Levaquin can alter the normal bacteria in the colon and cause pseudomembranous colitis. Patients taking Levaquin can develop photosensitivity.

The usual dose of Levaquin is 250-750 mg given once daily for 5-60 days depending on the type of infection. Antacid or mineral supplements containing iron, calcium, zinc, or magnesium bind Levaquin and prevent its absorption into the body. Fluoroquinolones may affect blood glucose control in diabetic patients. Levaquin has not been adequately evaluated in pregnant women and is not recommended for use in lactating women because of the risk of adverse effects in the infant.

Our Levaquin Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is Patient Information in Detail?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Levaquin in Detail - Patient Information: Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using levofloxacin and call your doctor at once if you have a serious side effect such as:

  • chest pain and severe dizziness, fainting, fast or pounding heartbeats;
  • sudden pain, snapping or popping sound, bruising, swelling, tenderness, stiffness, or loss of movement in any of your joints;
  • diarrhea that is watery or bloody;
  • confusion, hallucinations, depression, tremors, feeling restless or anxious, unusual thoughts or behavior, insomnia, nightmares, seizure (convulsions);
  • severe headache, ringing in your ears, nausea, vision problems, pain behind your eyes;
  • pale skin, fever, weakness, easy bruising or bleeding;
  • nausea, upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
  • urinating less than usual or not at all;
  • numbness, burning pain, or tingly feeling in your hands or feet;
  • the first sign of any skin rash, no matter how mild; or
  • severe skin reaction -- fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain, followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.

Less serious side effects may include:

  • mild diarrhea, constipation, vomiting;
  • sleep problems (insomnia);
  • mild headache or dizziness; or
  • vaginal itching or discharge.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Levaquin (Levofloxacin) »

What is Patient Information Overview?

A concise overview of the drug for the patient or caregiver from First DataBank.

Levaquin Overview - Patient Information: Side Effects

SIDE EFFECTS: See also Warning section.

Nausea, diarrhea, headache, dizziness, lightheadedness, or trouble sleeping may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.

Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.

Use of this medication for prolonged or repeated periods may result in oral thrush or a new yeast infection. Contact your doctor if you notice white patches in your mouth, a change in vaginal discharge, or other new symptoms.

Tell your doctor right away if any of these serious side effects occur: easy bruising/bleeding, signs of a new infection (such as fever, persistent sore throat), change in the amount of urine.

Get medical help right away if any of these serious side effects occur: chest pain, severe/persistent headache, vision changes, shaking (tremors), seizures, severe dizziness, fainting, fast/irregular heartbeat, mental/mood changes (such as nervousness, confusion, hallucinations, depression, rare thoughts of suicide), signs of liver problems (such as persistent nausea/vomiting, stomach/abdominal pain, unusual tiredness, yellowing eyes/skin, dark urine).

Rarely, this medication may cause serious, possibly permanent, nerve problems (peripheral neuropathy). Stop taking levofloxacin and tell your doctor right away if you have any of the following symptoms: pain/numbness/burning/tingling/weakness in your arms, hands, legs, or feet, changes in how you sense touch/pain/temperature/vibration/body position.

This medication may rarely cause a severe intestinal condition (Clostridium difficile-associated diarrhea) due to a resistant bacteria. This condition may occur during treatment or weeks to months after treatment has stopped. Do not use anti-diarrhea products or narcotic pain medications if you have any of the following symptoms because these products may make them worse. Tell your doctor immediately if you develop: persistent diarrhea, abdominal or stomach pain/cramping, blood/mucus in your stool.

A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.

This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

In the US -

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

Read the entire patient information overview for Levaquin (Levofloxacin)»

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Levaquin FDA Prescribing Information: Side Effects
(Adverse Reactions)

SIDE EFFECTS

Serious And Otherwise Important Adverse Reactions

The following serious and otherwise important adverse drug reactions are discussed in greater detail in other sections of labeling:

Hypotension has been associated with rapid or bolus intravenous infusion of LEVAQUIN® . LEVAQUIN® should be infused slowly over 60 to 90 minutes, depending on dosage [see DOSAGE AND ADMINISTRATION].

Crystalluria and cylindruria have been reported with quinolones, including LEVAQUIN® . Therefore, adequate hydration of patients receiving LEVAQUIN® should be maintained to prevent the formation of a highly concentrated urine [see DOSAGE AND ADMINISTRATION].

Clinical Trial Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

The data described below reflect exposure to LEVAQUIN® in 7537 patients in 29 pooled Phase 3 clinical trials. The population studied had a mean age of 50 years (approximately 74% of the population was < 65 years of age), 50% were male, 71% were Caucasian, 19% were Black. Patients were treated with LEVAQUIN® for a wide variety of infectious diseases [see INDICATIONS AND USAGE]. Patients received LEVAQUIN® doses of 750 mg once daily, 250 mg once daily, or 500 mg once or twice daily. Treatment duration was usually 3-14 days, and the mean number of days on therapy was 10 days.

The overall incidence, type and distribution of adverse reactions was similar in patients receiving LEVAQUIN® doses of 750 mg once daily, 250 mg once daily, and 500 mg once or twice daily. Discontinuation of LEVAQUIN® due to adverse drug reactions occurred in 4.3% of patients overall, 3.8% of patients treated with the 250 mg and 500 mg doses and 5.4% of patients treated with the 750 mg dose. The most common adverse drug reactions leading to discontinuation with the 250 and 500 mg doses were gastrointestinal (1.4%), primarily nausea (0.6%); vomiting (0.4%); dizziness (0.3%); and headache (0.2%). The most common adverse drug reactions leading to discontinuation with the 750 mg dose were gastrointestinal (1.2%), primarily nausea (0.6%), vomiting (0.5%); dizziness (0.3%); and headache (0.3%).

Adverse reactions occurring in ≥ 1% of LEVAQUIN®-treated patients and less common adverse reactions, occurring in 0.1 to < 1% of LEVAQUIN®-treated patients, are shown in Table 6 and Table 7, respectively. The most common adverse drug reactions ( ≥ 3%) are nausea, headache, diarrhea, insomnia, constipation, and dizziness.

Table 6: Common ( ≥ 1%) Adverse Reactions Reported in Clinical Trials with LEVAQUIN®

System/Organ Class Adverse Reaction %
(N=7537)
Infections and Infestations moniliasis 1
Psychiatric Disorders insomnia* [see WARNINGS AND PRECAUTIONS] 4
Nervous System Disorders headache 6
dizziness [see WARNINGS AND PRECAUTIONS] 3
Respiratory, Thoracic and Mediastinal Disorders dyspnea [see WARNINGS AND PRECAUTIONS] 1
Gastrointestinal Disorders nausea 7
diarrhea 5
constipation 3
abdominal pain 2
vomiting 2
dyspepsia 2
Skin and Subcutaneous Tissue Disorders rash [seeWARNINGS AND PRECAUTIONS] pruritus 2
1
Reproductive System and Breast Disorders vaginitis 1†
General Disorders and Administration Site Conditions edema 1
injection site reaction 1
chest pain 1
* N=7274
† N=3758 (women)

Table 7: Less Common (0.1 to 1%) Adverse Reactions Reported in Clinical Trials with LEVAQUIN® (N=7537)

System/Organ Class Adverse Reaction
Infections and Infestations genital moniliasis
Blood and Lymphatic System Disorders anemia thrombocytopenia granulocytopenia [see WARNINGS AND PRECAUTIONS]
Immune System Disorders allergic reaction [see WARNINGS AND PRECAUTIONS]
Metabolism and Nutrition Disorders hyperglycemia hypoglycemia [see WARNINGS AND PRECAUTIONS] hyperkalemia
Psychiatric Disorders anxiety agitation confusion depression hallucination nightmare* [see WARNINGS AND PRECAUTIONS]sleep disorder* anorexia abnormal dreaming*
Nervous System Disorders tremor convulsions [see WARNINGS AND PRECAUTIONS] paresthesia [see WARNINGS AND PRECAUTIONS)] vertigo hypertonia hyperkinesias abnormal gait somnolence* syncope
Respiratory, Thoracic and Mediastinal Disorders epistaxis
Cardiac Disorders cardiac arrest palpitation ventricular tachycardia ventricular arrhythmia
Vascular Disorders phlebitis
Gastrointestinal Disorders gastritis stomatitis pancreatitis esophagitis gastroenteritis glossitis pseudomembranous/ C. difficile colitis [see WARNINGS AND PRECAUTIONS]
Hepatobiliary Disorders abnormal hepatic function increased hepatic enzymes increased alkaline phosphatase
Skin and Subcutaneous Tissue Disorders urticaria [see WARNINGS AND PRECAUTIONS]
Musculoskeletal and Connective Tissue Disorders arthralgia tendinitis [see WARNINGS AND PRECAUTIONS)] myalgia skeletal pain
Renal and Urinary Disorders abnormal renal function acute renal failure [see WARNINGS AND PRECAUTIONS]
* N = 7274

In clinical trials using multiple-dose therapy, ophthalmologic abnormalities, including cataracts and multiple punctate lenticular opacities, have been noted in patients undergoing treatment with quinolones, including LEVAQUIN®. The relationship of the drugs to these events is not presently established.

Postmarketing Experience

Table 8 lists adverse reactions that have been identified during post-approval use of LEVAQUIN®. Because these reactions are reported voluntarily from a population of uncertain size, reliably estimating their frequency or establishing a causal relationship to drug exposure is not always possible.

Table 8: Postmarketing Reports Of Adverse Drug Reactions

System/Organ Class Adverse Reaction
Blood and Lymphatic System Disorders pancytopenia aplastic anemia leukopenia hemolytic anemia [see WARNINGS AND PRECAUTIONS] eosinophilia
Immune System Disorders hypersensitivity reactions, sometimes fatal including: anaphylactic/anaphylactoid reactions anaphylactic shock angioneurotic edema serum sickness [see WARNINGS AND PRECAUTIONS]
Psychiatric Disorders psychosis paranoia isolated reports of suicide attempt and suicidal ideation [see WARNINGS AND PRECAUTIONS]
Nervous System Disorders exacerbation of myasthenia gravis [see WARNINGS AND PRECAUTIONS] anosmia ageusia parosmia dysgeusia peripheral neuropathy (may be irreversible) [see WARNINGS AND PRECAUTIONS] isolated reports of encephalopathy abnormal electroencephalogram (EEG) dysphonia pseudotumor cerebri [see WARNINGS AND PRECAUTIONS]
Eye Disorders Uveitis vision disturbance, including diplopia visual acuity reduced vision blurred scotoma
Ear and Labyrinth Disorders hypoacusis tinnitus
Cardiac Disorders isolated reports of torsade de pointes electrocardiogram QT prolonged [see WARNINGS AND PRECAUTIONS] tachycardia
Vascular Disorders vasodilatation
Respiratory, Thoracic and Mediastinal Disorders isolated reports of allergic pneumonitis [see WARNINGS AND PRECAUTIONS]
Hepatobiliary Disorders hepatic failure (including fatal cases) hepatitis jaundice [see WARNINGS AND PRECAUTIONS]
Skin and Subcutaneous Tissue Disorders bullous eruptions to include: Stevens-Johnson Syndrome toxic epidermal necrolysis erythema multiforme [see WARNINGS AND PRECAUTIONS] photosensitivity/phototoxicity reaction [see WARNINGS AND PRECAUTIONS] leukocytoclastic vasculitis
Musculoskeletal and Connective Tissue Disorders tendon rupture [seeWARNINGS AND PRECAUTIONS] muscle injury, including rupture rhabdomyolysis
Renal and Urinary Disorders interstitial nephritis [see WARNINGS AND PRECAUTIONS]
General Disorders and Administration Site Conditions multi-organ failure pyrexia
Investigations prothrombin time prolonged international normalized ratio prolonged muscle enzymes increased

Read the entire FDA prescribing information for Levaquin (Levofloxacin) »

A A A

Levaquin - User Reviews

Levaquin User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Levaquin sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.